FDA Import Refusal UPS-4046606-2/3/1 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA refused shipment UPS-4046606-2/3/1 from Boehringer Ingelheim Pharma GmbH & Co. KG (Germany) on Jan 14, 2016. The refused product falls under Drugs and Biologics — MELOXICAM (ANTI-INFLAMMATORY, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 14, 2016
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 62YCB07 MELOXICAM (ANTI-INFLAMMATORY, PART II)
- Charges
- 75